V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167365 | 20063879 | 1.59 | 100 | Curative (C) | 2018-01-01 | 2018-01-08 | ECX | N | N | ECX | 101623744 |
| 20167369 | 20063880 | 1.66 | 84.5 | Adjuvant (A) | 2017-11-02 | 2017-11-04 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101071043 |
| 20167371 | 20063881 | 1.71 | null | Palliative (P) | 2016-11-28 | 2016-12-06 | ECX | N | N | ECX | 101154305 |
| 20167375 | 20063882 | 1.7 | 63.7 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-14 | ECX | N | N | ECX | 100712856 |
| 20167382 | 20063883 | 1.67 | 78.45 | Neo-adjuvant (N) | 2019-11-17 | 2019-11-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100592398 |
| 20167383 | 20063884 | null | null | Palliative (P) | 2018-09-16 | 2018-09-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100502758 |
| 20167387 | 20063885 | 1.6 | 59.9 | Palliative (P) | null | 2017-06-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101614767 |
| 20167388 | 20063886 | 1.59 | 88 | Palliative (P) | 2018-09-18 | 2018-10-01 | ECX | N | N | ECX | 101100008 |
| 20167396 | 20063887 | 1.83 | 67.4 | Palliative (P) | 2016-05-04 | 2016-05-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101484957 |
| 20167397 | 20063888 | 1.58 | 56.9 | Neo-adjuvant (N) | 2017-05-01 | 2017-05-10 | ECX | N | N | ECX | 101785937 |
| 20167398 | 20063889 | 1.81 | 86 | Palliative (P) | 2017-12-24 | 2017-12-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100942416 |
| 20167409 | 20063890 | 1.72 | 77.6 | null | null | 2016-07-21 | ECX | N | N | ECX | 101289187 |
| 20167419 | 20063891 | 1.67 | 62 | Neo-adjuvant (N) | 2016-06-09 | 2016-06-15 | ECX | N | N | ECX | 101695128 |
| 20167422 | 20063892 | 1.82 | 67.3 | Palliative (P) | 2018-08-04 | 2018-08-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100810967 |
| 20167428 | 20063893 | 1.61 | 82.6 | Neo-adjuvant (N) | 2018-07-24 | 2018-07-25 | ECX | N | N | ECX | 100259855 |
| 20167437 | 20063894 | 1.78 | 103.2 | Palliative (P) | 2017-11-15 | 2017-11-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101567371 |
| 20167443 | 20063895 | 1.63 | 68.5 | Neo-adjuvant (N) | 2019-07-16 | 2019-07-21 | ECX | N | N | ECX | 100160756 |
| 20167445 | 20063896 | null | null | Palliative (P) | 2016-06-29 | 2016-07-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100536873 |
| 20167449 | 20063897 | 1.76 | 82.9 | Adjuvant (A) | 2016-04-10 | 2016-04-18 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 101736974 |
| 20167451 | 20063898 | 1.65 | 47.7 | Adjuvant (A) | 2018-01-22 | 2018-02-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101037697 |
| 20167460 | 20063899 | 1.54 | 74 | 03 | 2016-04-10 | 2016-04-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101581072 |
| 20167462 | 20063900 | 1.77 | 72.6 | null | 2016-07-27 | 2016-07-28 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100443931 |
| 20167465 | 20063901 | 1.61 | 62.2 | Palliative (P) | 2016-11-04 | 2016-11-17 | ECX | 02 | N | ECX | 101647483 |
| 20167470 | 20063902 | 1.49 | 72.3 | Neo-adjuvant (N) | 2018-02-20 | 2018-02-24 | ECX | N | N | ECX | 100361064 |
| 20167473 | 20063903 | 1.73 | 112 | Neo-adjuvant (N) | null | 2017-12-02 | ECX | 02 | N | ECX | 101313159 |
| 20167476 | 20063904 | 1.76 | 106.6 | Palliative (P) | 2016-06-15 | 2016-06-24 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101072840 |
| 20167481 | 20063905 | 1.77 | 95 | Curative (C) | 2019-01-25 | 2019-02-01 | ECX | 2 | N | ECX | 100639144 |
| 20167482 | 20063906 | 1.69 | 85.4 | Palliative (P) | 2020-01-13 | 2020-01-15 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100566862 |
| 20167489 | 20063907 | 1.86 | 52 | Adjuvant (A) | 2019-05-13 | 2019-05-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100969857 |
| 20167491 | 20063908 | 1.56 | 94 | null | 2016-09-29 | 2016-09-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100464451 |
| 20167493 | 20063909 | 1.69 | 80.6 | Adjuvant (A) | 2018-01-19 | 2018-01-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100202491 |
| 20167504 | 20063910 | 0 | 47.8 | null | 2017-09-20 | 2017-10-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100010453 |
| 20167510 | 20063911 | 1.54 | 44.1 | Adjuvant (A) | 2018-07-28 | 2018-08-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100212452 |
| 20167519 | 20063912 | 1.71 | 78.7 | Palliative (P) | 2016-11-15 | 2016-11-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101816156 |
| 20167525 | 20063913 | 1.69 | 88.5 | Adjuvant (A) | null | 2017-11-15 | Fluouracil continuous infusion | 2 | N | FLUOROURACIL | 100009444 |
| 20167526 | 20063914 | 1.79 | 73.2 | Adjuvant (A) | 2017-09-22 | 2017-10-11 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100707861 |
| 20167531 | 20063915 | 1.77 | 105 | Curative (C) | 2017-06-15 | 2017-06-18 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100668824 |
| 20167532 | 20063916 | 1.73 | 102.2 | Adjuvant (A) | 2019-10-06 | 2019-10-23 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101207852 |
| 20167534 | 20063917 | 1.75 | 82.7 | Neo-adjuvant (N) | 2016-12-27 | 2017-01-20 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101246019 |
| 20167547 | 20063918 | 1.61 | 72 | Adjuvant (A) | 2016-07-10 | 2016-07-13 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101233919 |
| 20167548 | 20063919 | 1.62 | 56.9 | Adjuvant (A) | 2020-02-24 | 2020-02-25 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101216307 |
| 20167559 | 20063920 | 1.81 | 102.9 | Palliative (P) | 2019-09-30 | 2019-10-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100171161 |
| 20167561 | 20063921 | 1.66 | 56.55 | Curative (C) | 2018-11-10 | 2018-12-22 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100148177 |
| 20167567 | 20063922 | 1.67 | 86.9 | Curative (C) | 2017-03-29 | 2017-03-29 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101416915 |
| 20167569 | 20063923 | 1.57 | 61 | Neo-adjuvant (N) | 2017-09-25 | 2017-10-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100194319 |
| 20167575 | 20063924 | 1.72 | 103 | Palliative (P) | 2016-11-25 | 2016-12-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100381598 |
| 20167577 | 20063925 | 1.76 | 74.9 | Palliative (P) | 2016-03-18 | 2016-03-19 | Fluouracil continuous infusion | 02 | N | FLUOROURACIL | 101041302 |
| 20167579 | 20063926 | 1.55 | 98 | Adjuvant (A) | 2018-11-02 | 2018-11-16 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100897337 |
| 20167580 | 20063927 | 1.75 | 60 | null | 2018-12-28 | 2019-01-10 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100386192 |
| 20167584 | 20063928 | 1.67 | 85.2 | Curative (C) | 2019-10-20 | 2019-11-01 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101709268 |